Furthermore, miR-891b increases the sensitivity of the BC cells to the cytotoxic effects of the chemotherapeutic DNA-damaging agent N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) by suppressing the expression of PARP1 [49]. The gene discussed is PARP1; the disease is breast cancer.